---
figid: PMC6295312__nihms-1515648-f0001
figtitle: Gene-level alterations in muscle-invasive bladder cancer in the context
  of curated pathways
organisms:
- Homo sapiens
pmcid: PMC6295312
filename: nihms-1515648-f0001.jpg
figlink: /pmc/articles/PMC6295312/figure/F1/
number: F1
caption: Gene-level alterations in muscle-invasive bladder cancer in the context of
  curated pathways. Figure adapted from []. Pathway members and interactions in ten
  selected pathways are shown, where gene-level alterations (e.g. mutations, copy
  number alterations, fusions, and epigenetic silencing) across the entire TCGA pan-cancer
  cohort were previously catalogued by the TCGA PanCanAtlas project, with the alteration
  frequencies for TCGA BLCA cases being represented here. Genes are altered at different
  frequencies (shading intensity indicating the average frequency of alteration across
  the TCGA BLCA cohort) by either oncogenic activation (for genes with oncogenic roles,
  alterations including activating mutations, fusions, and gene amplifications) or
  tumor suppressor inactivation (for genes with tumor suppressive roles, alterations
  including inactivating mutations, epigenetic silencing, and gene deletions). Italicized
  genes without boxes denote genes with close to 0% alteration frequencies.
papertitle: The clinical applications of the cancer genome atlas project for bladder
  cancer.
reftext: Chad J. Creighton. Expert Rev Anticancer Ther. 2018 Oct;18(10):973-980.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7852942
figid_alias: PMC6295312__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6295312__F1
ndex: c3ad48af-de98-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6295312__nihms-1515648-f0001.html
  '@type': Dataset
  description: Gene-level alterations in muscle-invasive bladder cancer in the context
    of curated pathways. Figure adapted from []. Pathway members and interactions
    in ten selected pathways are shown, where gene-level alterations (e.g. mutations,
    copy number alterations, fusions, and epigenetic silencing) across the entire
    TCGA pan-cancer cohort were previously catalogued by the TCGA PanCanAtlas project,
    with the alteration frequencies for TCGA BLCA cases being represented here. Genes
    are altered at different frequencies (shading intensity indicating the average
    frequency of alteration across the TCGA BLCA cohort) by either oncogenic activation
    (for genes with oncogenic roles, alterations including activating mutations, fusions,
    and gene amplifications) or tumor suppressor inactivation (for genes with tumor
    suppressive roles, alterations including inactivating mutations, epigenetic silencing,
    and gene deletions). Italicized genes without boxes denote genes with close to
    0% alteration frequencies.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - GABPA
  - NFE2L2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - KEAP1
  - CUL3
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - PDGFRA
  - FGFR2
  - FGFR1
  - FGFR3
  - FGFR4
  - IGF1R
  - KIT
  - INPP4B
  - RET
  - ROS1
  - ALK
  - FLT3
  - NTRK1
  - JAK2
  - AKT1
  - PPP2R1A
  - TGFB1
  - TGFB2
  - TGFB3
  - CBL
  - ERRFI1
  - ABL1
  - SOS1
  - NF1
  - RASA1
  - SYNGAP1
  - STK11
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - INHBA
  - INHBB
  - PTPN11
  - RIT1
  - BCL11B
  - RICTOR
  - MTOR
  - RPTOR
  - TGFBR1
  - TGFBR2
  - ACVR2A
  - ACVR1B
  - MAPKAP1
  - MLST8
  - ARAF
  - BRAF
  - RAF1
  - RNASE3
  - ZHX2
  - SMAD2
  - SMAD3
  - RAC1
  - RNASE1
  - MAPK1
  - MAP2K2
  - MAP2K1
  - TP53
  - TP63
  - TP73
  - SMAD4
  - MAP2K7
  - MDM4
  - MDM2
  - CDKN2A
  - ATM
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MYC
  - WIF1
  - CHEK1
  - CHEK2
  - SFRP1
  - MYCN
  - MYCL
  - RPS6KA3
  - RNF43
  - DKK4
  - DKK1
  - DKK2
  - DKK3
  - LRP5
  - ZNRF3
  - MAX
  - MGA
  - MGAM
  - GSK3B
  - AXIN1
  - AXIN2
  - CTNNB1
  - MXD1
  - MXI1
  - MNT
  - APC
  - PROC
  - AMER1
  - CDKN2B
  - CDKN1A
  - CDPF1
  - CDKN1B
  - TCF7
  - TLE3
  - TLE2
  - TLE4
  - TLE1
  - TCF7L2
  - MLX
  - MLXIPL
  - CCNE1
  - RB1
  - RBM45
  - CCND1
  - CCND3
  - CCND2
  - HNF4A
  - MLXIP
  - E2F1
  - UBE2L3
  - CDK6
  - CDK4
  - DCHS1
  - DCHS2
  - FAT3
  - FAT4
  - FAT1
  - FAT2
  - TAOK1
  - TAOK2
  - TAOK3
  - TAAR9
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - JAG2
  - ARRDC1
  - FBXW7
  - CUL1
  - SAV1
  - STK3
  - STK24
  - STK4
  - NF2
  - LATS1
  - CD79A
  - PSMB5
  - WWC1
  - CCN3
  - PLXNA1
  - RPL10
  - MAML3
  - KAT2B
  - CREBBP
  - CNTN6
  - EP300
  - YAP1
  - PTPN14
  - CRB1
  - CRB2
  - TAFAZZIN
  - WWTR1
  - CSNK1E
  - CSNK1D
  - DNER
  - PSEN2
  - SPEN
  - RBM15
  - NCOR1
  - KDM5A
  - TEAD2
  - APBA1
  - MOB1B
  - Breast cancer
  - Cancer
  - Cardiomyopathy
  - Cholangiocarcinoma
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
